Tonix Pharmaceuticals Holding (TNXP) Current Leases (2019 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Current Leases came in at $162000.0 in Q1 2026, down 31.06% year-on-year from $235000.0 in Q1 2025, and up 29.6% quarter-over-quarter from $125000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Current Leases (2019 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Current Leases history runs 8 years deep, the most recent figure standing at $162000.0 for Q1 2026.
- On a quarterly basis, Current Leases fell 31.06% year-over-year to $162000.0 in Q1 2026; TTM through Mar 2026 was $162000.0, a 31.06% decrease from a year earlier, with the FY2025 full-year figure at $125000.0, down 54.38% from the prior year.
- Current Leases climbed to $162000.0 in Q1 2026 per TNXP's latest filing, from $125000.0 in the prior quarter.
- Across five years, Current Leases topped out at $511000.0 in Q2 2022 and bottomed at $125000.0 in Q4 2025.
- The 5-year median for Current Leases is $277000.0 (2024), against an average of $317705.9.
- Across the five-year window, Current Leases grew 10.33% in 2023 and sank 54.38% in 2025, its largest moves.
- Year by year, Current Leases stood at $432000.0 in 2022, then tumbled by 37.5% to $270000.0 in 2023, then climbed by 1.48% to $274000.0 in 2024, then sank by 54.38% to $125000.0 in 2025, then climbed by 29.6% to $162000.0 in 2026.
- Per Business Quant, the three latest TNXP Current Leases figures stand at $162000.0 (Q1 2026), $125000.0 (Q4 2025), and $159000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn | 162,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 162,000.00 |
| Dec 31, 2025 | 125,000.00 |
| Sep 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 195,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | 275,000.00 |
| Jun 30, 2024 | 277,000.00 |
| Mar 31, 2024 | 277,000.00 |
| Dec 31, 2023 | 270,000.00 |
| Sep 30, 2023 | 434,000.00 |
| Jun 30, 2023 | 436,000.00 |
| Mar 31, 2023 | 438,000.00 |
| Dec 31, 2022 | 432,000.00 |
| Sep 30, 2022 | 504,000.00 |
| Jun 30, 2022 | 511,000.00 |
| Mar 31, 2022 | 397,000.00 |
| Dec 31, 2021 | 489,000.00 |
| Sep 30, 2021 | 583,000.00 |
| Jun 30, 2021 | 500,000.00 |